Tsochatzis, Emmanuel
The Royal Free Hospital · University College London
18 papers on CoChatORCID 0000-0001-5069-2461
Most cited papers
- Verified
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 3,119
- Verified
Advancing the global public health agenda for NAFLD: a consensus statement
Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., et al. (2022) · Nature Reviews Gastroenterology & Hepatology
Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects
Cited by 757
- Verified
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
Petroff, D., Blank, V., Newsome, P. N., Shalimar, Voican, C. S., Thiele, M., de Lédinghen, V., Baumeler, S., Chan, W. K., Perlemuter, G., et al. (2021) · The Lancet Gastroenterology & Hepatology
Liver Disease Diagnosis and TreatmentUltrasound Imaging and Elastography
Cited by 268
- Verified
Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease
Pons, M., Augustin, S., Scheiner, B., Guillaume, M., Rosselli, M., Rodrigues, S. G., Stefanescu, H., Ma, M. M., Mandorfer, M., Mergeay-Fabre, M., et al. (2021) · American Journal of Gastroenterology
Liver Disease and TransplantationLiver Disease Diagnosis and Treatment
Cited by 260
- Verified
Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease
Lin, H., Lee, H. W., Yip, T. C.-F., Tsochatzis, E., Petta, S., Bugianesi, E., Yoneda, M., Zheng, M.-H., Hagström, H., Boursier, J., et al. (2024) · JAMA
Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation
Cited by 250
- Verified
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
Mózes, F. E., Lee, J. A., Vali, Y., Alzoubi, O., Staufer, K., Trauner, M., Paternostro, R., Stauber, R. E., Holleboom, A. G., van Dijk, A.-M., et al. (2023) · The Lancet Gastroenterology & Hepatology
Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation
Cited by 214
- Verified
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis
Younossi, Z. M., Zelber-Sagi, S., Lazarus, J. V., Wong, V. W.-S., Yilmaz, Y., Duseja, A., Eguchi, Y., Castera, L., Pessoa, M. G., Oliveira, C. P., et al. (2025) · Gastroenterology
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 194
- Verified
MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation
Böttcher, K., Rombouts, K., Saffioti, F., Roccarina, D., Rosselli, M., Hall, A., Luong, T., Tsochatzis, E. A., Thorburn, D., & Pinzani, M. (2018) · Hepatology
Liver Diseases and ImmunityLiver physiology and pathology
Cited by 183
- Verified
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study
Israelsen, M., Torp, N., Johansen, S., Hansen, C. D., Hansen, E. D., Thorhauge, K., Hansen, J. K., Villesen, I., Bech, K., Wernberg, C., et al. (2024) · The Lancet Gastroenterology & Hepatology
Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects
Cited by 174
- Verified
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation
Ravikumar, R., Tsochatzis, E., Jose, S., Allison, M., Athale, A., Creamer, F., Gunson, B., Iyer, V., Madanur, M., Manas, D., et al. (2015) · Journal of Hepatology
Liver Diseases and ImmunityOrgan Transplantation Techniques and Outcomes
Cited by 173
- Verified
International liver transplantation consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation
Tsochatzis, E., Coilly, A., Nadalin, S., Levistky, J., Tokat, Y., Ghobrial, M., Klinck, J., & Berenguer, M. (2019) · Transplantation
Organ Transplantation Techniques and OutcomesLiver Disease Diagnosis and Treatment
Cited by 105
- Verified
Non-invasive prediction of high-risk varices in patients with primary biliary cholangitis and primary sclerosing cholangitis
Moctezuma-Velazquez, C., Saffioti, F., Tasayco-Huaman, S., Casu, S., Mason, A., Roccarina, D., Vargas, V., Nilsson, J.-E., Tsochatzis, E., Augustin, S., et al. (2019) · American Journal of Gastroenterology
Liver Disease and TransplantationLiver Diseases and Immunity
Cited by 78
- Verified
Definition of healthy ranges for alanine aminotransferase levels: a 2021 update
Valenti, L., Pelusi, S., Bianco, C., Ceriotti, F., Berzuini, A., Iogna Prat, L., Trotti, R., Malvestiti, F., D’Ambrosio, R., Lampertico, P., et al. (2021) · Hepatology Communications
Liver Disease Diagnosis and TreatmentClinical Laboratory Practices and Quality Control
Cited by 77
- Verified
Implementation of a liver health check in people with type 2 diabetes
Abeysekera, K. W. M., Valenti, L., Younossi, Z., Dillon, J. F., Allen, A. M., Noureddin, M., Rinella, M. E., Tacke, F., Francque, S., Ginès, P., et al. (2024) · The Lancet Gastroenterology & Hepatology
Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation
Cited by 63
- Verified
Management of metabolic syndrome and cardiovascular risk after liver transplantation
Fatourou, E. M., & Tsochatzis, E. A. (2019) · The Lancet Gastroenterology & Hepatology
Organ Transplantation Techniques and OutcomesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 59
- Verified
Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis
Buzzetti, E., Linden, A., Best, L. M., Madden, A. M., Roberts, D., Chase, T. J. G., Freeman, S. C., Cooper, N. J., Sutton, A. J., Fritche, D., et al. (2021) · Cochrane Database of Systematic Reviews
Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects
Cited by 46
- Verified
Evaluation of recipients with significant comorbidity - patients with cardiovascular disease
Tsochatzis, E. A., Watt, K. D., VanWagner, L. B., Verna, E. C., & Berzigotti, A. (2023) · Journal of Hepatology
Organ Transplantation Techniques and OutcomesLiver Disease and Transplantation
Cited by 22
- Verified
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis
Komolafe, O., Buzzetti, E., Linden, A., Best, L. M., Madden, A. M., Roberts, D., Chase, T. J., Fritche, D., Freeman, S. C., Cooper, N. J., et al. (2021) · Cochrane Database of Systematic Reviews
Liver Disease Diagnosis and TreatmentSilymarin and Mushroom Poisoning
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free